SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051413
Filing Date
2020-11-05
Accepted
2020-11-05 16:45:44
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-10q_20200930.htm   iXBRL 10-Q 2243887
2 EX-31.1 arvn-ex311_9.htm EX-31.1 19376
3 EX-31.2 arvn-ex312_8.htm EX-31.2 19375
4 EX-32.1 arvn-ex321_6.htm EX-32.1 9493
5 EX-32.2 arvn-ex322_7.htm EX-32.2 9415
  Complete submission text file 0001564590-20-051413.txt   7200019

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arvn-20200930.xsd EX-101.SCH 51401
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arvn-20200930_cal.xml EX-101.CAL 46635
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arvn-20200930_def.xml EX-101.DEF 171769
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20200930_lab.xml EX-101.LAB 394639
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20200930_pre.xml EX-101.PRE 305100
11 EXTRACTED XBRL INSTANCE DOCUMENT arvn-10q_20200930_htm.xml XML 1111878
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 201291222
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences